$8.48
0.020.24%
At close: Sep 18, 5:00 PM EST
$8.50
0.020.24%
After Hours: Sep 18, 7:52 PM EST
ImmunityBio Inc
IBRXNASDAQ
ImmunityBio Earnings & Forecasts
ImmunityBio (IBRX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
ImmunityBio Guidance
ImmunityBio (IBRX) last issued guidance on July 25, 2025 for Q2 2025. The company guided revenue in the range of $26.4M - $26.4M for the period.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.08 | $-0.07 | $-0.09 | $-0.10 |
| Actual | $-0.08 | $-0.08 | $-0.06 | $-0.07 |
| Surprise | +3.75% | -14.3% | +33.3% | +30.0% |
| Revenue | ||||
| Estimate | $49.0M | $43.4M | $37.5M | $31.0M |
| Actual | $51.2M | $44.2M | $38.3M | $32.1M |
| Surprise | +4.47% | +1.93% | +2.07% | +3.39% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.06 | $-0.05 | $-0.09 | $-0.09 |
| Revenue | ||||
| Consensus | $59.5M | $72.1M | — | — |
